La tunisie Medicale - 2022 ; Vol 100 ( n°08 ) : 611-617
[ Vu 570 fois ]
Résumé

Objectifs: Estimer la prévalence des symptômes digestifs du bas du tube digestif chez les patients diabétiques de type 2 et identifier les facteurs associés à leur survenue.
Méthodes: Une étude transversale a été réalisée chez des diabétiques de type 2 recrutés dans les centres de santé de base des régions de Sousse et de Monastir (Tunisie). Le diagnostic des symptômes digestifs a été confirmé selon les critères de Rome III. Ont été étudié les influences des caractéristiques sociodémographiques, du mode de vie, des habitudes alimentaires, des caractéristiques du diabète, de la somatisation, de l’état psychologique (Echelle HAD) et de la qualité de vie (Echelle SF-12), sur la prévalence des symptômes digestifs chez les diabétiques.
Résultats: Un total de 417 diabétiques de type 2 ont été inclus. L’âge moyen était de 61,3±10,4 ans avec une prédominance féminine (68,8%). La prévalence globale des symptômes digestifs était de 44,8%, dont essentiellement le ballonnement abdominal (18,9%), les diarrhées (11,7%), la constipation (8,6%), le syndrome de l’intestin irritable (8,6%) et l’incontinence fécale (8,2%). L’analyse multi variée par régression logistique a identifié six facteurs associés aux symptômes digestifs qui sont l’intolérance alimentaire (OR=2,28; IC=[2-5,31]), la demande de soins pour un problème digestif (OR=2,95; IC=[1,49-5,83]), la prise d’un traitement antiacide (OR=4,22; IC=[1,13-15,69]), la rétinopathie diabétique (OR=2,66; IC=[1,52-4,7]), la somatisation (OR=1,75; IC=[1,06-2,88]) et un état de santé mentale altéré (OR=2,8; IC=[1,66-4,72]).
Conclusion: Les symptômes digestifs occasionnaient une importante demande de soins et une altération de la qualité de vie chez les diabétiques de type 2, d’où l’importance de leur recherche systématique.

Mots Clés
Article
Références
  1. Saidi O, O’Flaherty M, Mansour NB, Aissi W, Lassoued O, Capewell S, et al. Forecasting Tunisian type 2 diabetes prevalence to 2027: validation of a simple model. BMC Public Health. 2015;15:104.
  2. Marathe CS RC, Wu T, et al. . Gastrointestinal Disorders in Diabetes. In: Feingold KR AB, Boyce A, et al., editors, editor. 2020, Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc; 2000.
  3. Abid S, Rizvi A, Jahan F, Rabbani F, Islam N, Khan MH, et al. Poor glycaemic control is the major factor associated with increased frequency of gastrointestinal symptoms in patients with diabetes mellitus. J Pak Med Assoc, 2007;57(7):345-9.
  4. Du YT, Rayner CK, Jones KL, Talley NJ, Horowitz M. Gastrointestinal Symptoms in Diabetes: Prevalence, Assessment, Pathogenesis, and Management. Diabetes Care, 2018;41(3):627-37.
  5. Black CJ, Drossman DA, Talley NJ, Ruddy J, Ford AC. Functional gastrointestinal disorders: advances in understanding and management. Lancet, 2020;396(10263):1664-74.
  6. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Internal Med, 2001;161(16):1989-96.
  7. Jeong HK HS, Soon YK, Sung NH, In-Kyung S, Chan SS et al. Diabetic factors associated with gastrointestinal symptoms in patients with type 2 diabetes. World J Gastroenteral. 2010;16(14).
  8. Onyekwere CA OO. Prevalence Of Gastrointestinal Symptoms In Diabetics In An Urban Hospital In Nigeria. The internet journal of endocrinology. 2007;4(1).
  9. Quan C, Talley NJ, Jones MP, Howell S, Horowitz M. Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population study. Eur J Gastroenterol Hepatol. 2008;20(9):888-97.
  10. Talley NJ, Howell S, Jones MP, Horowitz M. Predictors of turnover of lower gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol. 2002;97(12):3087-94.
  11. Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G, et al. The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med. 2011;39(1):105-11.
  12. Portincasa P, Bonfrate L, Wang DQ, Frühbeck G, Garruti G, Di Ciaula A. Novel insights into the pathogenic impact of diabetes on the gastrointestinal tract. Eur J Clin Invest. 2022.
  13. Raymond T, Raymond R, Lincoff AM. Management of the patient with diabetes and coronary artery disease: a contemporary review. Future Cardiol. 2013;9(3):387-403.
  14. Nompleggi D, Bell SJ, Blackburn GL, Bistrian BR. Overview of gastrointestinal disorders due to diabetes mellitus: emphasis on nutritional support. JPEN J Parenter Enteral Nutr. 1989;13(1):84-91.
  15. Ko GT, Chan WB, Chan JC, Tsang LW, Cockram CS. Gastrointestinal symptoms in Chinese patients with Type 2 diabetes mellitus. Diabet Med. 1999;16(8):670-4.
  16. Bastyr EJ, 3rd, Price KL, Bril V. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clin Ther. 2005;27(8):1278-94.
  17. Standards of medical care in diabetes-2010. Diabetes Care. 2010 Jan;33 Suppl 1:S11-61.
  18. Drossman DA, Dumitrascu DL. Rome III: New standard for functional gastrointestinal disorders. J Gastrointestin Liver Dis. 2006;15(3):237-41.
  19. Hammer J, Eslick GD, Howell SC, Altiparmak E, Talley NJ. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut. 2004;53(5):666-72.
  20. Attanasio V, Andrasik F, Blanchard EB, Arena JG. Psychometric properties of the SUNYA revision of the Psychosomatic Symptom Checklist. J Behav Med. 1984;7(2):247-57.
  21. Roberge P, Dore I, Menear M, Chartrand E, Ciampi A, Duhoux A, et al. A psychometric evaluation of the French Canadian version of the Hospital Anxiety and Depression Scale in a large primary care population. J Affect Disord. 2012.147(1-3):171-9
  22. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-70.
  23. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51(11):1171-8.
  24. Guermazi M, Allouch C, Yahia M, Huissa TB, Ghorbel S, Damak J, et al. Translation in Arabic, adaptation and validation of the SF-36 Health Survey for use in Tunisia. Ann Phys Rehabil Med. 2012 ;55(6):388-403.
  25. Ware J, Jr., Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-33.
  26. Oh JH, Choi MG, Kang MI, Lee KM, Kim JI, Kim BW, et al. The prevalence of gastrointestinal symptoms in patients with non-insulin dependent diabetes mellitus. Korean J Intern Med. 2009;24(4):309-17.
  27. Feldman M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med. 1983;98(3):378-84.
  28. Ito H, Ito K, Tanaka M, Hokamura M, Kusano E, Kondo J, et al. Constipation Is a Frequent Problem Associated with Vascular Complications in Patients with Type 2 Diabetes: A Cross-sectional Study. Intern Med. 2022;61(9):1309-17.
  29. Asgharnezhad M, Joukar F, Fathalipour M, Khosousi M, Hassanipour S, Pourshams A, et al. Gastrointestinal symptoms in patients with diabetes mellitus and non-diabetic: A cross-sectional study in north of Iran. Diabetes Metab Syndr. 2019;13(3):2236-40.
  30. Ricci JA, Siddique R, Stewart WF, Sandler RS, Sloan S, Farup CE. Upper gastrointestinal symptoms in a U.S. national sample of adults with diabetes. Scand J Gastroenterol. 2000;35(2):152-9.
  31. Bytzer P, Howell S, Leemon M, Young LJ, Jones MP, Talley NJ. Low socioeconomic class is a risk factor for upper and lower gastrointestinal symptoms: a population based study in 15 000 Australian adults. Gut. 2001;49(1):66-72.
  32. Maleki D, Locke GR, 3rd, Camilleri M, Zinsmeister AR, Yawn BP, Leibson C, et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch intern Med. 2000;160(18):2808-16.
  33. Nanda R, James R, Smith H, Dudley CR, Jewell DP. Food intolerance and the irritable bowel syndrome. Gut. 1989;30(8):1099-104.
  34. Simren M, Mansson A, Langkilde AM, Svedlund J, Abrahamsson H, Bengtsson U, et al. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion. 2001;63(2):108-15.
  35. Scadding G, Bjarnason I, Brostoff J, Levi AJ, Peters TJ. Intestinal permeability to 51Cr-labelled ethylenediaminetetraacetate in foodintolerant subjects. Digestion. 1989;42(2):104-9.
  36. Gui XY. Mast cells: a possible link between psychological stress, enteric infection, food allergy and gut hypersensitivity in the irritable bowel syndrome. J Gastroentero Hepatol. 1998;13(10):980-9.
  37. Ma C, Congly SE, Novak KL, Belletrutti PJ, Raman M, Woo M, et al. Epidemiologic Burden and Treatment of Chronic Symptomatic Functional Bowel Disorders in the United States: A Nationwide Analysis. Gastroenterology. 2021;160(1):88-98.e4.
  38. Fujishiro M, Kushiyama A, Yamazaki H, Kaneko S, Koketsu Y, Yamamotoya T, et al. Gastrointestinal symptom prevalence depends on disease duration and gastrointestinal region in type 2 diabetes mellitus. World J Gastroenterol. 2017;23(36):6694-704.
  39. Wienbeck M, Erckenbrecht J, Strohmeyer G. Effect of antacids on intestinal motility. Z Gastroenterol. 1983;21 Suppl:111-6.
  40. Talley NJ, Young L, Bytzer P, Hammer J, Leemon M, Jones M, et al. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol. 2001;96(1):71-6.
  41. Azpiroz F, Malagelada C. Diabetic neuropathy in the gut: pathogenesis and diagnosis. Diabetologia. 2016;59(3):404-8.
  42. Lustman PJ, Griffith LS, Clouse RE, Cryer PE. Psychiatric illness in diabetes mellitus. Relationship to symptoms and glucose control. J Nerv Ment Dis. 1986;174(12):736-42.
  43. Gavard JA, Lustman PJ, Clouse RE. Prevalence of depression in adults with diabetes. An epidemiological evaluation. Diabetes Care. 1993;16(8):1167-78.
  44. Drossman DA, McKee DC, Sandler RS, Mitchell CM, Cramer EM, Lowman BC, et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology. 1988;95(3):701-8.
  45. Talley NJ, Phillips SF, Bruce B, Twomey CK, Zinsmeister AR, Melton LJ, 3rd. Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome. Gastroenterology. 1990;99(2):327-33.
  46. Quan C, Talley NJ, Jones MP, Spies J, Horowitz M. Gain and loss of gastrointestinal symptoms in diabetes mellitus: associations with psychiatric disease, glycemic control, and autonomic neuropathy over 2 years of follow-up. Am J Gastroenterol. 2008;103(8):2023-30.
Espace membre
E-mail :
Mot passe :
Mémoriser Mot de passe oublié S'inscrire
Archives
2022
Janvier
Février
Mars
Avril
Mai
Juin
Juillet
Août
Septembre
Octobre
Novembre
Décembre
Mots-clés
Enfant traitement Tunisie pronostic Chirurgie diagnostic Maladie de crohn facteurs de risque prévalence dépistage Cancer du sein Cancer obésité Mortalité Coelioscopie
Newsletter
S'inscrire pour recevoir les newsletters
E-mail :
Partagez
Rejoignez-nous !